Proteome Sciences Share Discussion Threads

[james japp] 13/2/2024 16:04

What a 'plan'.

Mothball the business with zero forward strategy.

[pools2] 13/2/2024 16:01

goatherd,

Agreed. Proteome Sciences state this in their reports and more recently in their webinars. Institutions and companies are now discovering the same Alzheimer's disease biomarkers that PRM have already discovered and patented.

[jeffian] 13/2/2024 15:59

Not so far, it isn't.

[goatherd] 13/2/2024 15:48

Proteome's strategy is quite clear.

They have not got the money to develop tests themselves. They will just keep monitoring other people's tests and see if any infringe PRM's patents.

If the tests do infringe they will then negotiate royalties.

Probably not as profitable as doing the development themselves; but very effective nonetheless.

[james japp] 13/2/2024 15:18

Good afternoon, The Bell.

"where have you read that"

On a free bb*













*forum

[the bull] 13/2/2024 15:07

large value deals, where have you read that. They seem to take so long, new treatments come and go.

[pools2] 13/2/2024 14:52

wasjobber,

I agree and as PRM continue to receive patent grants for their newer Alzheimer's disease patent portfolio we could also see some significant moves in the share price as large value deals in Alzheimer's disease are completed.

[james japp] 13/2/2024 10:43

I note that in addition to the absence of trades (none again so far today) that on the LSE 'Chat' there hasnt been a single post since 30th November last year.

[base7] 13/2/2024 10:30

If pressed ,James, I could be tempted by £8 per share or I may be tempted to hold for £10,depending on how good the news is - that is £8 per share-not for my total holding ?

[peverill] 12/2/2024 19:02

I see we are a step closer to a blood test for dementia,a university having identified certain markers.I thought PRM were ahead of the curve on this one,apparently not.

[monte1] 12/2/2024 13:31

Quite, it is mystery wrapped in an enigma for sure.

[monte1] 12/2/2024 13:17

I expect he will shortly storm enraged from a board meeting to tell an anonymous avatar to set us straight on that matter James.

[james japp] 12/2/2024 13:15

I dont think Mr Pearce would accept anything less than £8, monte1.


vbrs
Peter Dawson

[monte1] 12/2/2024 13:14

Stake-building as a pre-curser to a hostile bid at a premium of many thousand percent of the current share price perhaps James?

[james japp] 12/2/2024 12:47

I note that the STRONG BUYER has been busy accumulating a further 80 shares from a weak holder this morning.

[james japp] 08/2/2024 10:30

Thanks vaston.

[vaston] 08/2/2024 10:25

SYME IS NOW READY TO FLY

[jeffian] 08/2/2024 10:24

LOL. Nice to have a scientific explanation!

"By attacking gunge called beta amyloid which builds up in the brains of people with Alzheimer's,..."

[monte1] 08/2/2024 09:34

Meanwhile;

[james japp] 08/2/2024 09:33

For every seller there is a STRONG BUYer monte1.

Albeit 40 quids worth, less £15 in trading costs, of course.

[monte1] 08/2/2024 09:27

Not such good news though James - it appears to have been a sell at bid. Perhaps a transfer from weak holder to strong hands?

[james japp] 08/2/2024 09:21

Welcome news!

There has been a trade.

[peverill] 08/2/2024 09:16

Whooooosh!!!